Virtual Roundtable Engagement

Beyond AI Experimentation—How Sponsors and CROs Can Deploy GxP-Ready AI Agents at Enterprise Scale

000 days 00 hours 00 minutes 00 seconds

June 30, 2026  |  12:00 pm - 1:30 pm EDT


In collaboration with

Register your Interest

Discussion Topics

 Why clinical operations remain the biggest bottleneck, and how agentic AI—grounded in regulatory frameworks—transforms the productivity curve.

 How sprint activation compresses the path from pilot to production, delivering measurable, enterprise-scale agent deployment.

 What's possible with CRA, TMF, and PI Summary Agents across QTL monitoring, compliance, and eCOA oversight.

 How to operationalize human-in-the-loop control, inspection readiness, and measurable accountability without slowing innovation.


Speakers

Angie Maurer

VP, AI-Enabled Clinical Development


Agenda

12.00 pm - 12.30 pm

Attendee Introduction

12.30 pm - 1.20 pm

Round table discussion for all attendees

1.20 pm - 1.30 pm

Closing remarks & key takeaways


Next Steps


Discussion Topics

• Why clinical operations remain the biggest bottleneck, and how agentic AI—grounded in regulatory frameworks—transforms the productivity curve.

• How sprint activation compresses the path from pilot to production, delivering measurable, enterprise-scale agent deployment.

• What's possible with CRA, TMF, and PI Summary Agents across QTL monitoring, compliance, and eCOA oversight.

• How to operationalize human-in-the-loop control, inspection readiness, and measurable accountability without slowing innovation.


Speakers

Angie Maurer

VP, AI-Enabled Clinical Development


Agenda

12.00 pm - 12.30 pm

Attendee Introduction

12.30 pm - 1.20 pm

Round table discussion for all attendees

1.20 pm - 1.30 pm

Closing remarks & key takeaways


Next Steps


Privacy Preference Center